A review of significance of Aspergillus detection in airways of ICU COVID‐19 patients. Issue 9 (1st July 2021)

• Record Type: Journal Article
• Authors: Pasquier, Grégoire; Bounhiol, Agathe; Robert Gangneux, Florence; Zahar, Jean‐Ralph; Gangneux, Jean Pierre; Novara, Ana; Bougnoux, Marie‐Elisabeth; Dannaoui, Eric
• Is Part Of: Mycoses. Volume 64:Issue 9(2021)
• Page Start: 980
• Page End: 988
• Publication Date: 2021-07-01
• Subjects: Aspergillus fumigatus -- colonisation -- COVID‐19 -- intensive care unit -- invasive pulmonary aspergillosis -- mortality -- SARS‐CoV‐2; Pathogenic fungi -- Periodicals; Medical mycology -- Periodicals; 616.969
• DOI: 10.1111/myc.13341
• Languages: English
• ISSNs: 0933-7407

Abstract

Abstract: It is now well known that patients with SARS‐CoV‐2 infection admitted in ICU and mechanically ventilated are at risk of developing invasive pulmonary aspergillosis (IPA). Nevertheless, symptomatology of IPA is often atypical in mechanically ventilated patients, and radiological aspects in SARS‐CoV‐2 pneumonia and IPA are difficult to differentiate. In this context, the significance of the presence of Aspergillus in airway specimens (detected by culture, galactomannan antigen or specific PCR) remains to be fully understood. To decipher the relevance of the detection of Aspergillus, we performed a comprehensive review of all published cases of respiratory Aspergillus colonisation and IPA in COVID‐19 patients. The comparison of patients receiving or not antifungal treatment allowed us to highlight the most important criteria for the decision to treat. The comparison of surviving and non‐surviving patients made it possible to unveil criteria associated with mortality that should be taken into account in the treatment decision.